Dr. Srilalitha Kuruganti

Head - Late Stage Development, Analytical

Dr. Srilalitha Kuruganti is currently leading the Late-stage Analytical Sciences division at CuraTeQ Biologics Pvt Ltd.

She has a Ph.D in Biochemistry, Cell and Molecular Biology from University of Tennessee-Knoxville and a Post Doctoral fellowship from the University of Alabama- Birmingham. She has published several research articles in peer-reviewed international journals. Dr. Srilalitha has more than 15 years of working experience in the USA in the field of biotherapeutics, molecular and cell biology, immunology, and protein chemistry. Prior to joining CuraTeQ, she worked as the Associate Director- Global Research and Development Division at Boehringer Ingelheim, USA.

Overview
CuraTeQ Biologics

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

You can adjust your preferences below.

Essential Cookies

Essential Cookies should be enabled at all times so that we can save your preferences for cookie settings. If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Google Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website.

Powered by  GDPR Cookie Compliance